Impact of Female Sex on Cardiogenic Shock Outcomes
Van‐Khue Ton(Massachusetts General Hospital), Navin K. Kapur(Tufts Medical Center), Maya Guglin(Indiana University Health), Peter Zazzali(Tufts Medical Center), Claudius Mahr(Medical City Dallas Hospital), Arvind Bhimaraj(Houston Methodist), A.R. Garan(Beth Israel Deaconess Medical Center), Shashank S. Sinha(Inova Fairfax Hospital), Rachna Kataria(Massachusetts General Hospital), Jaime Hernández-Montfort(Baylor Scott & White Health), Maryjane Farr(Columbia University), Daniel Burkhoff(Columbia University Irving Medical Center), Song Li(University of Pittsburgh), Wissam Khalife(The University of Texas Medical Branch at Galveston), Andrew Schwartzman(Maine Medical Center), Mohit Pahuja, Manreet Kanwar(University of Chicago), Elric Zweck(Düsseldorf University Hospital), Esther Vorovich(Northwestern University), Jacob Abraham(Providence St. Vincent Medical Center), Karol Walec(Tufts Medical Center), Detlef Wencker(Baylor Scott & White Health), Saraschandra Vallabhajosyula, Ju H. Kim(Houston Methodist), Vanessa Blumer(Massachusetts General Hospital), Paavni Sangal(Tufts Medical Center), Gavin Hickey(University of Pittsburgh Medical Center), Neil Harwani(Tufts Medical Center), Yijing Zhang(Donghua University), Borui Li(Tufts Medical Center), Sandeep Nathan(University of Chicago), Shelley Hall
Cited by 49
Related Papers
COVID-19 in solid organ transplant recipients: Initial report from the US epicenter
|American Journal of Transplantation|2020|837
The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial
|Nature Medicine|2021|599
Criteria for Defining Stages of Cardiogenic Shock Severity
|Journal of the American College of Cardiology|2022|283
The continuous heart failure spectrum: moving beyond an ejection fraction classification
|European Heart Journal|2019|258